# FDA 483 - Susan Seedman, M.D. - August 30, 2024

Source: https://www.globalkeysolutions.net/records/483/susan-seedman-md/333b9f32-307b-4151-983e-432665248bc6

> FDA 483 for Susan Seedman, M.D. on August 30, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Susan Seedman, M.D.
- Inspection Date: 2024-08-30
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Susan Seedman, M.D. in Rio Rancho, NM, revealed significant deficiencies in clinical trial conduct. Observations included failures to adhere to investigational plans, specifically regarding subject eligibility and timely reporting of serious adverse events. Additionally, informed consent documents lacked crucial information about compensation for research-related injuries.

## Related Officers

- [Logan M. Jones](https://www.globalkeysolutions.net/people/logan-m-jones/286ab813-461a-4bfc-a732-bcd4f0d6e596)

Company: https://www.globalkeysolutions.net/companies/susan-seedman-md/78ffb309-01a1-418a-a458-069b13f04efa

Office: https://www.globalkeysolutions.net/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face